Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis

Published:2020-12 Issue:6 Volume:7 Page:3298-3309
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Butler Javed¹,Usman Muhammad Shariq²,Khan Muhammad Shahzeb¹,Greene Stephen J.³,Friede Tim⁴⁵,Vaduganathan Muthiah⁶,Filippatos Gerasimos⁷,Coats Andrew J. Stewart⁸⁹,Anker Stefan D.¹⁰

Affiliation:

1. Department of Medicine University of Mississippi Medical Center 2500 N. State Street Jackson MS 39216 USA

2. Department of Medicine Dow University of Health Sciences Karachi Pakistan

3. Division of Cardiology Duke University Medical Center Durham NC USA

4. Department of Medical Statistics University Medical Center Goettingen Goettingen Germany

5. DZHK (German Center of Cardiovascular Research), partner site Goettingen Goettingen Germany

6. Heart and Vascular Center Brigham and Women's Hospital Boston MA USA

7. National and Kapodistrian University of Athens School of Medicine Athens University Hospital Attikon Athens Greece

8. Department of Cardiology IRCCS San Raffaele Pisana Rome Italy

9. University of Warwick Coventry UK

10. Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK), partner site Berlin Charité Universitätsmedizin Berlin Augustenburger Platz 1 D‐13353 Berlin Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13169

Reference27 articles.

1. SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects

2. Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: A systematic review and meta-analysis

3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

4. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

5. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of sodium-glucose transporter 2 inhibitors on stroke in patients with type 2 diabetes: A meta-analysis;Journal of Stroke and Cerebrovascular Diseases;2024-08

2. Effect of sex on sodium‐glucose co‐transporter‐2 antagonists and glucagon‐like peptide‐1 agonists in heart failure;ESC Heart Failure;2024-07-23

3. 20 Years of triple-valve surgery in the UK: demographic and outcome trends;European Journal of Cardio-Thoracic Surgery;2024-07-01

4. Sodium–Glucose Transporter 2 Inhibitors in Heart Failure: An Overview of Systematic Reviews;Journal of Cardiovascular Development and Disease;2024-06-28

5. Effect of Luhong formula on the cardiac rehabilitation of patients with chronic heart failure;World Journal of Clinical Cases;2024-06-16